Summary: Haematological variables in patients with eosinophilia and in healthy control subjects were studied in order to determine whether there were abnormalities in the coagulation system in patients. We found significantly elevated levels of fibrinogen, fibrin degradation products, platelet number and Pthromboglobulin in patients. The abnormalities were not related to the causes of eosinophilia nor to its severity. This lack of correlation could be due to the heterogeneity ofhuman peripheral blood eosinophils.
Introduction
Thromboembolic disorders are often observed in patients with the hypereosinophilic syndrome (HES)''2 but the causes are unresolved. Eosinophil granule proteins are believed to play two roles in thrombosis: whereas the major basic protein could produce endothelial damage,3 the cationic protein might produce a hypercoagulable state. 4 However, no previous systematic study of possible 
Results
The results are given in Tables I and II. Significant differences were observed between patients and control subjects for fibrinogen levels (P < 0.001), platelet number (P<0.005) and P-TG (P<0.001). In addition, the PF4 level tended to be higher in patients than in controls, although that difference was not significant. There was no significant correlation between the severity of eosinophilia and abnormalities in the coagulation tests. Although patients with vasculitis, solid tumours and lymphoproliferative syndromes showed the most marked individual haemostatic abnormalities, there were no significant differences among the various disease groups (Table III) The absence of any correlation between the severity of the eosinophilia and the different coagulation parameters, such as PF4 and P-TG levels, might be due to the heterogeneity of the human peripheral blood eosinophils,13 and specifically, to the mechanisms of eosinophil degranulation.14 The lack of differences among different groups ofdiseases can be attributed to this same mechanism or to the small number of patients in each group.
